Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

The Original Article was published on 11 May 2020

Correction to: Nature Medicine https://doi.org/10.1038/s41591-020-0860-1, published online 11 May 2020.

In the version of this article initially published, three accession numbers (EGAS00001004229, EGAS00001004386 and EGAS00001004387) were missing from the Data Availability Statement in the HTML. The correct statement is as follows: “Raw data analyzed in this study have been submitted to the European Genome-Phenome Archive with accession numbers EGAS00001004008, EGAS00001004229, EGAS00001004230, EGAS00001004386 and EGAS00001004387.” The error has been corrected in the HTML version of the article. Also, the original Reporting Summary file has been replaced with a revised file that includes these accession numbers.

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Mahrukh A. Huseni or Sanjeev Mariathasan.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yuen, K.C., Liu, LF., Gupta, V. et al. Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat Med 27, 560 (2021). https://doi.org/10.1038/s41591-021-01246-4

Download citation

Search

Quick links